Ginkgo Bioworks Provides Preliminary Unaudited 2022 Revenue Highlights and Business ReviewPRNewsWire • 01/11/23
Prokarium and Ginkgo Bioworks Announce Partnership to Discover Multiple Targets for RNA Therapeutics and Immuno-oncologyPRNewsWire • 01/09/23
Ginkgo Bioworks Expands Its R&D Facilities, Opens Bioworks7 to Conduct Mammalian Screening at Scale, Widening Capabilities for Biopharma PartnersPRNewsWire • 01/06/23
Esperovax and Ginkgo Bioworks Announce Partnership to Develop Circular RNA-based TherapeuticsPRNewsWire • 01/05/23
Ginkgo Bioworks Announces Participation in the 41st Annual J.P. Morgan Healthcare ConferencePRNewsWire • 01/04/23
Ginkgo Bioworks and the Ministry of Health of the Republic of Botswana Announce Plans to Develop and Implement New Biosecurity Capabilities in BotswanaPRNewsWire • 12/20/22
Top Wall Street Firm Has 5 Stocks Under $10 With 160% to 970% Upside Potential24/7 Wall Street • 12/10/22
Ginkgo Bioworks Launches Ginkgo Enzyme Services, Enabling Applications across Pharmaceuticals and Diagnostics, Food and Agriculture, and BeyondPRNewsWire • 12/08/22
Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/14/22